Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Diagnostics (Basel, Switzerland)|July 27, 2022
Unlocking the Potential of the Human Microbiome for Identifying Disease Diagnostic BiomarkersRima Hajjo, Dima A Sabbah, Abdel Qader Al Bawab
ACS Omega|April 28, 2025
Unraveling the Anticancer Potential of SSRIs in Prostate Cancer by Combining Computational Systems Biology and <i>In Vitro</i> AnalysesSanaa K Bardaweel, Esraa Jaradat, Rima Hajjo, et al.
International Journal of Environmental Research and Public Health|January 8, 2020
Salivary Microbiome and Cigarette Smoking: A First of Its Kind Investigation in JordanWalid Al-Zyoud, Rima Hajjo, Ahmed Abu-Siniyeh, et al.
Vaccines|October 26, 2021
Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine RecipientsRima Hajjo, Dima A Sabbah, Sanaa K Bardaweel, et al.
Current Computer-Aided Drug Design|August 21, 2020
An Integrative Informatics Approach to Explain the Mechanism of Action of N1-(Anthraquinon-2-yl) Amidrazones as BCR/ABL InhibitorsDima A Sabbah, Rima Hajjo, Kamal Sweidan, et al.
Diagnostics (Basel, Switzerland)|April 30, 2021
Identification of Tumor-Specific MRI Biomarkers Using Machine Learning (ML)Rima Hajjo, Dima A Sabbah, Sanaa K Bardaweel, et al.
Analytical Methods : Advancing Methods and Applications|October 15, 2025
Carvedilol microemulsion-loaded oleogel: development and validation <i>via</i> an HPLC method, identification of three degradation products, and toxicity predictionIbtihal Abuhamdeh, Rania Hamed, Rima Hajjo, et al.
Expert Opinion on Therapeutic Patents|May 10, 2021
Phosphatidylinositol 3-kinase (PI3K) inhibitors: a recent update on inhibitor design and clinical trials (2016-2020)Dima A Sabbah, Rima Hajjo, Sanaa K Bardaweel, et al.
Plos One|October 10, 2025
DPP4 inhibitors as a novel therapeutic strategy in colorectal cancer: Integrating network biology and experimental insightsSanaa K Bardaweel, Baraa Abu Sneineh, Rima Hajjo, et al.
Expert Opinion on Therapeutic Patents|April 1, 2024
Targeting the PI3K/AKT signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020-2023)Dima A Sabbah, Rima Hajjo, Sanaa K Bardaweel, et al.
Pageof 5